<DOC>
	<DOC>NCT00717834</DOC>
	<brief_summary>The primary objective of this study is to assess the safety and tolerability of the Ross River Virus (RRV) Vaccine in a healthy young adult population. Other objectives of this study are to assess the immunogenicity of the RRV Vaccine in a healthy young adult population and to identify the optimal dose level of the RRV Vaccine in a healthy young adult population.</brief_summary>
	<brief_title>Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Formaldehyde</mesh_term>
	<criteria>Are 18 to 40 years of age, inclusive, on the day of screening; Have an understanding of the study and its procedures, agree to its provisions, and give written informed consent prior to study entry; Are generally healthy; Are physically and mentally capable of participating in the study and following study procedures; Agree to keep a daily record of symptoms for the duration of the study; If female of childbearing potential have a negative urine pregnancy test result within 24 hours of the scheduled first vaccination and agree to employ adequate birth control measures for the duration of the study. Have a history of RRV exposure or a history of travel to a RRV endemic area: Australia, West Papua, Papua New Guinea, Solomon Islands, New Caledonia, Fiji Islands, Samoa Islands and Cook Island; Have a Body Mass Index &gt; 35; Have an elevated blood pressure at screening of &gt; 159 mmHg systolic and/or &gt; 99 mmHg diastolic while seated and at rest and confirmed by two additional measurements taken at least 30 minutes apart (while seated and at rest); Have clinically significant abnormal clinical laboratory values at screening; Have clinically significant electrocardiographic abnormalities at screening; Test positive for Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HbsAg) or Hepatitis C Virus (HCV); Have a history of cardiovascular disease; Have a history of immunodeficiency or autoimmune diseases; Have a history of arthritis (joint swelling, tenderness, warmth or erythema) on more than one occasion, not related to trauma (including running) or any episode of nontrauma related arthritis within the previous 6 months; Have an active neoplastic disease or have a history of hematological malignancy; Have a disease or are undergoing a form of treatment that can be expected to influence immune response. Such treatment includes, but is not limited to, systemic or high dose inhaled (&gt; 800 mg/day of beclomethasone dipropionate or equivalent), corticosteroids, radiation treatment or other immunosuppressive or cytotoxic drugs; Have a history of inflammatory or degenerative neurological disease (eg Guillain Barr√©, multiple sclerosis); Have received any vaccination within 2 weeks prior to vaccination in this study; Have received a blood transfusion or immunoglobulins within 30 days prior to vaccination in this study; Have donated blood or plasma within 30 days prior to vaccination in this study; Have a history of any vaccine related contraindicating event (eg, anaphylaxis, allergy to components of the test vaccine, other known contraindications); Have a rash, dermatologic condition or tattoos which may interfere with injection site reaction rating; Have a positive urine drug screen, (unless the detected drug is currently prescribed by a licensed health care provider and the continued administration of the drug would not otherwise exclude the subject from participation); Were administered an investigational drug within 6 weeks prior to study entry; Are concurrently participating in a clinical study that includes the administration of an investigational product; Are a member of the team conducting this study; Are in a dependent relationship with one of the study team members. Dependent relationships include close relatives (ie, children, partner/spouse, siblings, parents) as well as employees of the investigator or site personnel conducting the study; If female, are pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>